Pharmafile Logo
Pharmafocus logo
Advanced Search

Ground-breaking COVID antibody treatment proven to save lives

June 16, 2021
Research and Development COVID-19, UK, antibodies, trial

Results from Regeneron’s Recovery trial, investigating a potent monoclonal antibody combination treatment in hospitalised patients with severe COVID-19, have shown …

News

Signite’s sustainable decorating solution to reduce label waste by 50%

June 16, 2021
Research and Development

ACTEGA has officially launched Signite, a new decorating solution designed to significantly reduce waste in label production. The hope is …

News

Avadel’s narcolepsy Phase III trial shows positive results

June 16, 2021
Research and Development

Avadel’s Phase III trial for FT218 in patients with narcolepsy has shown positive results. The data from the trial demonstrated …

News
az

AstraZeneca antibody fails to prevent COVID in exposed patients

June 15, 2021
Manufacturing and Production AstraZeneca, COVID-19, Primary Endpoint, antibody, trial

AstraZeneca has failed to reach the primary endpoint in their Storm Chaser trial, assessing the safety and efficacy of AZD7442, …

News

Novo Holdings acquires BBI Group in £400 million deal

June 15, 2021
Manufacturing and Production acqusition, deal, finance

Novo Holdings, a holding company of the Novo Group, has acquired BBI Group from Exponent for an enterprise value of …

News

Biogen Phase III choroideremia study did not meet primary endpoint

June 15, 2021
Manufacturing and Production Biogen, choroideremia, phase III

Biogen has announced that its investigational gene therapy study for the potential treatment of choroideremia did not meet its primary …

News
integration_of_nvd-001_in_intervertebral_body_cage_fusion

Bone regeneration stem cell “putty” sees positive results in trials

June 15, 2021
Manufacturing and Production Cell regeneration, Stem cells, bone, platform, technology

Belgian clinical stage company, Novadip Biosciences, has announced positive results from its Phase I trial of its autologous cell-based osteogenic …

News

Cognito Therapeutics initiates Down syndrome Alzheimer’s study

June 15, 2021
Manufacturing and Production

Cognito Therapeutics are going to run a second digital therapeutic study evaluating individuals who have the genetic rare disease, Down …

News
janssen_latest_logo_on_sign_closer

Janssen CLL treatment combination sees success in trials

June 14, 2021
Sales and Marketing CLL, Janssen

Janssen has announced positive data from its Phase III GLOW study, with the combination of imbruvica (ibrutinib) plus venetoclax (I+V) …

News
astrazeneca_sign_sky

EMA official recommends avoiding AstraZeneca vaccine

June 14, 2021
Sales and Marketing

A senior executive at the EMA recommended abandoning the use of the AstraZeneca vaccine in the EU where alternatives are …

News

NICE recommends treatments for rare form of colorectal cancer

June 14, 2021
Sales and Marketing

NICE has recommended BMS’s nivolumab plus ipilimumab (also known as Opdivo and Yervoy) to treat people with a rare form …

News
image_readtop_2018_569751_15365546683454581

Experimental COVID antibody treatment successful in trials

June 14, 2021
Sales and Marketing COVID-19, antibody therapy, celltrion, phase III

Celltrion has announced positive top-line data for its experimental antibody COVID-19 treatment, with Phase III trials finding it safe and …

News
johnson_and_johnson_jj

Germany demands that J&J replace contaminated vaccine doses

June 14, 2021
Sales and Marketing

Germany’s health ministry has demanded that J&J must deliver 6.5 million COVID-19 vaccine doses to Germany in July to make …

News

Third FDA panel member quits over controversial Alzheimer’s drug approval

June 11, 2021
Medical Communications

The third FDA advisory panel member has quit over the approval of a controversial new Alzheimer’s drug. Biogen’s drug, aducanumab, …

News

“The future of pain care”: Virtual reality therapy proven to aid chronic pain

June 11, 2021
Medical Communications CBT, Virtual reality, chronic pain management, technology

A novel digital therapeutics software, DTxP, has shown statistically significant benefits for patients with chronic low back pain (CLBP) in …

News

G7: UK to donate 100 million surplus vaccine doses

June 11, 2021
Medical Communications Boris Johnson, COVID-19, G7, Joe Biden, UK, US, Vaccine

Boris Johnson has announced at the G7 meeting in Cornwall that the UK will donate over 100 million surplus doses …

News
sanofi_hq__boetie_hall_web

Sutimlimab meets primary endpoint in treating cold agglutinin disease

June 11, 2021
Medical Communications

A Phase III study evaluating the safety and efficacy of sutimlimab in people with cold agglutinin disease (CAD) met its …

News
top_10_image_2_9

Pharmafile.com’s top 10 news stories of the week

June 11, 2021
Medical Communications

Among our ten most-read stories this week: AstraZeneca vs GSK: Cancer drug court battle could cost hundreds of millions; New …

News

Phase III breast cancer trial meets primary endpoint

June 10, 2021

Byondis has revealed positive Phase III results for (ADC) [vic-]trastuzumab duocarmazine (SYD985) in patients with HER2-positive unresectable locally advanced or …

News
covid_cell_1_20

Pharmafile.com’s weekly COVID-19 news round-up

June 10, 2021

The past week has seen lots of vaccine-related news, Pfizer-BioNTech has expanded its COVID-19 vaccine study in children under 12, …

News
The Gateway to Local Adoption Series

Latest content

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026

Sandoz’ Ondibta receives European Commission approval for diabetes

January 26, 2026

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026